activity
20222025
most citedGenerative Flows on Synthetic Pathway for Drug Design

4 citations · 8 across the 6 of their papers we have counts for

collaborators

6 papers

cs.AI2025

Accelerating Scientific Discovery with Autonomous Goal-evolving Agents

Yuanqi Du, Botao Yu, Tianyu Liu +25

There has been unprecedented interest in developing agents that expand the boundary of scientific discovery, primarily by optimizing quantitative objective functions specified by s…

cs.LG2025★ 1 cited

Compositional Flows for 3D Molecule and Synthesis Pathway Co-design

Tony Shen, Seonghwan Seo, Ross Irwin +4

Many generative applications, such as synthesis-based 3D molecular design, involve constructing compositional objects with continuous features. Here, we introduce Compositional Gen…

q-bio.BM2024★ 4 cited

Generative Flows on Synthetic Pathway for Drug Design

Seonghwan Seo, Minsu Kim, Tony Shen +4

Generative models in drug discovery have recently gained attention as efficient alternatives to brute-force virtual screening. However, most existing models do not account for synt…

cs.LG2024

Geometric-informed GFlowNets for Structure-Based Drug Design

Grayson Lee, Tony Shen, Martin Ester

The rise of cost involved with drug discovery and current speed of which they are discover, underscore the need for more efficient structure-based drug design (SBDD) methods. We em…

cs.LG2023★ 1 cited

TacoGFN: Target-conditioned GFlowNet for Structure-based Drug Design

Tony Shen, Seonghwan Seo, Grayson Lee +5

Searching the vast chemical space for drug-like molecules that bind with a protein pocket is a challenging task in drug discovery. Recently, structure-based generative models have…

cs.LG2022★ 2 cited

Semi-Supervised Junction Tree Variational Autoencoder for Molecular Property Prediction

Atia Hamidizadeh, Tony Shen, Martin Ester

Molecular Representation Learning is essential to solving many drug discovery and computational chemistry problems. It is a challenging problem due to the complex structure of mole…